Correction. Ketamine vs Electroconvulsive Therapy in the Management of Treatment-Resistant Depression: Do We Need More Data?

In the brief report “Ketamine vs Electroconvulsive Therapy in the Management of Treatment-Resistant Depression: Do We Need More Data?” by Taeho Greg Rhee, PhD, and colleagues published online January 27, 2025 (J Clin Psychiatry 2025;86[1]:24br15655), the SD, SMD, and 95% CI values in the Anand, Total, and Heterogeneity rows in Figure 1A (MADRS section only) and Figure 1B have been corrected. In the first sentence of the Results, the total and subset numbers of patients have been corrected. To reflect the data corrections, changes have been made to the Results section and the first and last paragraphs of the Discussion to clarify that the findings, consistent with an earlier study, indicate that electroconvulsive therapy may be superior to ketamine for improving depression severity in the acute phase, but treatments did not significantly differ in terms of response and remission as outcomes.

Published Online: February 11, 2025. 
DOI: 10.4088/JCP.25lcx15827
J Clin Psychiatry 2025;86(1):25lcx15827